Registration of healthcare products in Ukraine

New Medicines Law, New Regulator, New Compliance Landscape

Cratia and CMS invite international pharmaceutical companies, as well as their business, legal and regulatory leaders, to a practical webinar focused on the upcoming transformation of Ukraine’s medicines regulatory framework.

Why it matters
With the entry into force of the new Law On Medicinal Products from 1 January 2027, companies operating in or supplying the Ukrainian market will face material changes across the entire product lifecycle, including marketing authorisation, market access, supply chain structures, pharmacovigilance, promotion and compliance requirements.

At the same time, a new central regulatory authority, the Ukrainian Pharmaceutical Agency, is currently being established and is expected to become operational from 1 January 2027, replacing the existing regulatory bodies and quality inspectorate. This will fundamentally reshape regulatory interactions, oversight and enforcement.

What you will gain
This session is designed to help international pharma organisations:
• anticipate regulatory, operational and governance impacts on their Ukraine business;
• identify where targeted, and in some cases significant, adaptations to global and regional frameworks may be required;
• plan a structured, compliant and timely transition of portfolios, corporate structures and internal processes.